Dr. Fatih Inci is currently working as a Research Scientist at Stanford University School of Medicine, Canary Center at Stanford for Cancer Early Detection. He has been guiding and working with a group of researchers, including postdoctoral fellows, graduate, undergraduate, and high school students, who focus on micro- and nano-technologies for biomedical and bioengineering applications. Dr. Inci received his B.Sc. degree at the Department of Molecular Biology and Genetics in 2007 with magna cum laude honor from Istanbul University (Turkey), and also studied as an Sokrates student at the Department of Biology in University of Groningen (Netherlands) in 2005. He received his Ph.D. degree at the Department of Molecular Biology-Genetics & Biotechnology with summa cum laude honor from Istanbul Technical University (Turkey) in 2013. During his Ph.D. studies, he was also appointed as a visiting scientist at University of New South Wales (Sydney, Australia) and University of Technology Sydney (Australia), as well as working as a research scholar/trainee at Brigham and Women’s Hospital (BWH)-Harvard Medical School, and Harvard-MIT Health Sciences and Technology Division (Boston, MA). Upon the completion of his Ph.D. studies, Dr. Inci worked as a postdoctoral research fellow at BWH-Harvard Medical School (2013-2014) and Stanford University School of Medicine (2014-2015).
Dr. Inci has published his research work in the most prestigious journals, including Proceedings of the National Academy of Sciences of the United States of America (PNAS), ACS Nano, Nature Scientific Reports, Nature Light: Science & Applications, Small, Lab on a chip, Advanced Science, Biomacromolecules, Advanced Drug Delivery Reviews, ACS Chemical Reviews, Biotechnology Advances, Annual Review of Medicine, Materials Today, Trends in Biotechnology. Besides his research publications, he has contributed to the publication of 7 book chapters (including 3 chapters in press) and 3 editorial/perspective papers. He is also editing 3 scientific books in the world's renowned publishers, i.e., Springer Press and World Scientific Publishing Company. His research findings have been presented in national and international conferences, ranging in geography from Barcelona to Osaka, Sydney to Boston, Rio de Janeiro to San Diego and Phoenix to San Francisco. Moreover, he has secured his research findings, technological developments, and scientific discoveries with 6 U.S. patents. Some of them have already been licensed by companies to produce commercial products in the United States, and distributed throughout the world. One such example is his patent in the field of forensics that has been translated into two viable commercial products (CSI-Q and NGDE) produced in the United States by DxNow, Inc.
Dr. Inci’s qualified scientific work has been highlighted and recognized by well-renowned national and international organizations as well as government entities, including National Institute of Health, Nature Medicine, Science AAAS, Popular Science, Newsweek, Boston University, Canary Center-Stanford University, Brigham & Women’s Hospital, A*STAR, Center for Integration of Medicine and Innovative Technology (CIMIT), and Epilepsy Foundation. He has also been awarded with various scholarships and grants from European Molecular Biology Organization-European Science Foundation (EMBO-ESF), American Chemical Society, and Turkey Scientific and Technological Research Society (TUBITAK). He is a professional member at the world’s largest and most prestigious scientific societies, including the American Association for the Advancement of Science (AAAS), Royal Society of Chemistry (RSC), American Association for Cancer Research (AACR), and National Postdoctoral Association (NPA).
Current Role at Stanford
Dr. Fatih Inci’s area of excellence in research is to create micro- and nano-scale platform technologies at the intersection of medicine, biomedical engineering, biotechnology, chemistry, and materials science by manipulating biomolecules, cells and viruses in small volumes that offers precise solutions for real-world challenges in clinical diagnostics, personalized medicine, early cancer detection, forensic science, and biomarker discovery.
SOME OF THE RESEARCH HIGHLIGHTS and NEWS
•New device selects healthy sperm (Stanford Medicine) (2018).
•WPI Researchers Play Critical Role to Create Sperm-Sorting Device That Could Improve IVF Success (Worcester Polytechnic Institute) (2018).
•Sperm ‘obstacle course’ created by scientists to select healthiest ones for IVF (The Independent UK) (2018).
•Separating the weak from the strong: New device sorts sperm (Scope by Stanford Medicine) (2018).
•Interview on Istanbul University, Science Faculty - Faculty Guide (2017).
•Bioengineering and Biomedicine - Interview on Crossing Paths (2017).
•RöporTAF Interview on TAV Network (2017).
•Scientists develop new HIV diagnostic device (Johns Hopkins News-Letter) (2016).
•Potential point-of-care diagnostic platform (EurekAlert – Science AAAS) (2015).
•A New Platform for Point-of-Care Diagnostics? (Optics&Photonics News) (2015).
•Universelle Diagnostik: Ein Bluttest für alles (Deutschlandfunk) (2015).
•Smarter, Cheaper Technologies Offer Improved Point-of-care Medicine (NIH – National Institue of Biomedical Imaging and Bioengineering) (2015).
•New HIV Test May Improve Point-of-care Medicine in Remote Regions (Journal of the American Medical Association (JAMA)) (2015).
•New Biosensing Platform to be used in Disease Detection (Dartmouth University)
•Paper and Phones Could Soon Diagnose Ebola and HIV for $1 (Newsweek) (MSN News) (2015).
•Biosensing Films and Smartphones Let Doctors Diagnose Disease from Anywhere (Popular Science) (2015).
•Bientôt un diagnostic médical avec son smartphone (Futura Sciences) (2015).
•Novel Biosensing Platform Could Remotely Diagnose Disease And Monitor Treatment (BioSpace) (2015).
•Smarter, cheaper technologies for improved point-of-care medicine in remote areas (Kurzweil Accelerating Intelligence) (2015).
•App may detect bacterial infections (TV news in WPLG TV, an affiliate of ABC News) (2015).
•Un sistema permite diagnosticar enfermedades por el cellular (Investigacion y Desarrollo) (2015).
•Smartphone accessory puts HIV diagnosis in doctors' pockets (Engadget) (2015).
•Cell Phone App Detects Bacteria and Infectious Diseases (HCP Live) (2015).
•New Biosensing Platform Could Quickly and Accurately Diagnose Disease and Monitor Treatment Remotely (Florida Atlantic University) (2015).
•Smart phone diagnosis? Biosensing platform quickly and accurately diagnoses disease and monitors treatment remotely (ScienceDaily) (2015).
•Smartphone App Detects Bacteria, Diseases (Highlights in Product, Design & Development) (Nature World News) (2015).
•Novel biosensing platform could remotely determine treatment options for HIV, E-coli (News-Medical Net) (2015)
•Nanomechanical motion of Escherichia coli adhered to a surface – (Canary Center at Stanford Newsletter) (2014).
•And so they beat on, flagella against the cantilever – (American Institute of Physics) (Phys.org) (EurekAlert – Science AAAS) (ScienceDaily) (Kurzweil Accelerating Intelligence) (2014).
•It’s flagella against the Cantilever for the fate of bacteria – (Boston University) (Science 2.0) (2014).
•Palo Alto Weekly - Stoking a passion for science (News Cover) (2014).
•Disposable Chips to Detect Antiepileptic Drug Serum Concentrations at the Point of Care using Nanoplasmonic Platform – Brigham & Women’s Hospital, BRIght Future Prize (Nature Medicine) (Brigham & Women’s Hospital) (2013).
Honors & Awards
Best paper award (co-authored research), XXVII SIBGRAPI Conference on Graphics, Patterns and Images, Rio de Janeiro, Brazil (2014)
Honorarium for Publication (along with Utkan Demirci and Onur Tokel), American Chemical Society (2014)
New Therapy Commercialization Grants Program (along with Utkan Demirci and Steven Schachter), Epilepsy Foundation (2014)
BRIght Future Prize (along with Utkan Demirci and Steven Schachter)., Brigham & Women’s Hospital (Boston, MA) (2013)
Biomedical Research Institute Innovation Award (along with Utkan Demirci, Onur Tokel and ShuQi Wang), Brigham & Women’s Hospital (Boston, MA) (2012)
Scientific Conference/Travel Grant, European Science Foundation – European Molecular Biology Organization (2011)
Scientific Travel Grant, Istanbul Technical University (Turkey) (2010-2011)
Enrolled to Ph.D. Program with undergraduate degree (the first student in the institute), Istanbul Technical University (Turkey) (2007-2013)
Ph.D. Fellowship, Turkey Scientific and Technological Research Society (TUBITAK) (2007-2012)
Elected as an Erasmus/Socrates Student, University of Groningen (Netherlands) (2005-2006)
Scholarship for Undergraduate Students with Honor Degree (only one student per year), Istanbul University (Turkey) (2003-2007)
Education & Certifications
Postdoctoral Research Fellow, Stanford University School of Medicine, Radiology Department, Canary Center (Stanford, CA) (2016)
Postdoctoral Research Fellow, Brigham and Women’s Hospital, Renal Division, Department of Biomedical Engineering, Harvard Medical School (Boston, MA) (2014)
Doctor of Philosophy, Istanbul Technical University, Molecular Biology-Genetics & Biotechnology (Turkey) (2013)
Research Scholar/Trainee, Brigham and Women’s Hospital, Renal Division, Department of Biomedical Engineering, Harvard Medical School (Boston, MA) (2012)
Visiting Researcher, University of New South Wales, School of Biotechnology and Biomolecular Sciences (Australia) (2010)
Visiting Researcher, University of Technology Sydney, Institute for Nanoscale Technology (Australia) (2010)
Science Baccalaureate Degree, Istanbul University, Department of Molecular Biology and Genetics (Turkey) (2007)
Sokrates Student, University of Groningen, Department of Biology (Netherlands) (2006)
Service, Volunteer and Community Work
Session Co-Chair, SPIE-Photonic West BIOS - Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases: Photonic Diagnosis IV (2018)
San Francisco, CA
Session Co-Chair, Global Technology Community (GTC), Point-of-Care Diagnostics Congress (2015)
San Diego, CA
"United States Patent Invention No. BWH 21303: Controlled Viable Release of Selectively Captured Label-Free Cells in Microchannels"
"United States Patent Invention No. BWH 22611: Methods for Bacteria Detection, Monitoring of Antibiotic Agents, and Energy Harvesting using Micromechanical Devices"
"United States Patent Stanford Docket No. 15-315: Quantitative Nanoplasmonic Platform for Multiple Targets"
"United States Patent WO/2014/008363: Detection, Capture and Quantification of Biological Moieties from Unprocessed Bodily Fluids using Nanoplasmonic Platform"
"United States Patent WO/2016/054295: Systems and Methods for Determining Probative Samples and Isolation and Quantitation of Cells"
"United States Patent WO/2016/138255 A1: Portable Lensless Wide-field Microscopy Imaging for Health-Care Applications using Digital In-line Holography and Multi-Frame Pixel Super-Resolution"